Oruka Therapeutics, Inc. · HAM:HQ1
Oruka Therapeutics, Inc. shareholders
As of Sep 30, 2026, 249 institutions reported holding Oruka Therapeutics, Inc. Largest: Fidelity, T. Rowe Price and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Oruka Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 10.1M | +1.09M | Nov 10, 2026 | |
| T. Rowe Price | 5.36M | +3.42M | Nov 16, 2026 | |
| BlackRock | 5.21M | +220K | Nov 13, 2026 | |
| Vanguard | 4.72M | +1.36M | Nov 16, 2026 | |
| Venrock Adviser, LLC | 4.15M | no change | Nov 16, 2026 | |
| Fairmount Funds Management LLC | 3.71M | no change | Nov 16, 2026 | |
| Capital Group | 3.43M | +27,427 | Nov 12, 2026 | |
| Rtw Investments, LP | 3.14M | no change | Nov 16, 2026 | |
| State Street | 2.82M | +144K | Nov 12, 2026 | |
| Paradigm Biocapital Advisors LP | 2.49M | +349K | Nov 16, 2026 |